The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.

Autor: Guinan, Kimberly1 (AUTHOR) kimberly.guinan@peripharm.com, Mathurin, Karine1 (AUTHOR) karine.mathurin@peripharm.com, Lachaine, Jean1,2 (AUTHOR) jean.lachaine@peripharm.com, Roc, Nancy Paul3 (AUTHOR) nancy.paulroc@abbvie.com, Bull, Sarah-Jane3 (AUTHOR) sarahjane.bull@abbvie.com, Tankala, Dipti3 (AUTHOR) dipti.tankala@abbvie.com, Barakat, Stephane3 (AUTHOR) stephane.s.barakat@abbvie.com, Manzoor, Beenish S.4 (AUTHOR) beenish.manzoor@abbvie.com, Hillis, Christopher5 (AUTHOR) hillisc@mcmaster.ca, Banerji, Versha6,7 (AUTHOR) vbanerji@cancercare.mb.ca
Zdroj: Cancers. Sep2024, Vol. 16 Issue 18, p3182. 17p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje